Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries.
The report details the trend, potential and market size of Nifedipine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Nifedipinemarket, defines the market attractiveness level of Nifedipine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Nifedipine industry, describes the types of Nifedipine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nifedipine market and the development prospects and opportunities of Nifedipine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nifedipine market in Chapter 13.
By Player:
Teva (Israel)
Shyndec (China)
Bayer (Germany)
Actavis (USA)
Pfizer (USA)
Huanghai (China)
Honglin (China)
Yabao (China)
By Type:
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
By End-User:
Primary Pulmonary Hypertension
Heart Failure
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Nifedipine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Nifedipine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Nifedipine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Nifedipine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Nifedipine Market Analysis and Outlook to 2022
-
7.1 Global Nifedipine Consumption (2017-2022)
-
7.2 United States Nifedipine Consumption (2017-2022)
-
7.3 Europe Nifedipine Consumption (2017-2022)
-
7.4 China Nifedipine Consumption (2017-2022)
-
7.5 Japan Nifedipine Consumption (2017-2022)
-
7.6 India Nifedipine Consumption (2017-2022)
-
7.7 South Korea Nifedipine Consumption (2017-2022)
8 Region and Country-wise Nifedipine Market Analysis and Outlook to 2028
-
8.1 Global Nifedipine Consumption Forecast (2022-2028)
-
8.2 United States Nifedipine Consumption Forecast (2022-2028)
-
8.3 Europe Nifedipine Consumption Forecast (2022-2028)
-
8.4 China Nifedipine Consumption Forecast (2022-2028)
-
8.5 Japan Nifedipine Consumption Forecast (2022-2028)
-
8.6 India Nifedipine Consumption Forecast (2022-2028)
-
8.7 South Korea Nifedipine Consumption Forecast (2022-2028)
9 Global Nifedipine Market Outlook by Types and Applications to 2022
-
9.1 Global Nifedipine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Nifedipine Controlled Release Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Nifedipine Extended Action Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Nifedipine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Primary Pulmonary Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Heart Failure Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Nifedipine Market Outlook by Types and Applications to 2028
-
10.1 Global Nifedipine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Nifedipine Controlled Release Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Nifedipine Extended Action Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Nifedipine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Primary Pulmonary Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Nifedipine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Nifedipine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Nifedipine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Nifedipine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Nifedipine Market Competitive Analysis
-
14.1 Teva (Israel)
-
14.1.1 Teva (Israel) Company Details
-
14.1.2 Teva (Israel) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Teva (Israel) Nifedipine Product and Service
-
14.2 Shyndec (China)
-
14.2.1 Shyndec (China) Company Details
-
14.2.2 Shyndec (China) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shyndec (China) Nifedipine Product and Service
-
14.3 Bayer (Germany)
-
14.3.1 Bayer (Germany) Company Details
-
14.3.2 Bayer (Germany) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer (Germany) Nifedipine Product and Service
-
14.4 Actavis (USA)
-
14.4.1 Actavis (USA) Company Details
-
14.4.2 Actavis (USA) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Actavis (USA) Nifedipine Product and Service
-
14.5 Pfizer (USA)
-
14.5.1 Pfizer (USA) Company Details
-
14.5.2 Pfizer (USA) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer (USA) Nifedipine Product and Service
-
14.6 Huanghai (China)
-
14.6.1 Huanghai (China) Company Details
-
14.6.2 Huanghai (China) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Huanghai (China) Nifedipine Product and Service
-
14.7 Honglin (China)
-
14.7.1 Honglin (China) Company Details
-
14.7.2 Honglin (China) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Honglin (China) Nifedipine Product and Service
-
14.8 Yabao (China)
-
14.8.1 Yabao (China) Company Details
-
14.8.2 Yabao (China) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Yabao (China) Nifedipine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Nifedipine
-
Figure Nifedipine Picture
-
Table Global Nifedipine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nifedipine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nifedipine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Nifedipine Consumption by Country (2017-2022)
-
Figure United States Nifedipine Consumption and Growth Rate (2017-2022)
-
Table Europe Nifedipine Consumption and Growth Rate (2017-2022)
-
Figure China Nifedipine Consumption and Growth Rate (2017-2022)
-
Figure Japan Nifedipine Consumption and Growth Rate (2017-2022)
-
Figure India Nifedipine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nifedipine Consumption and Growth Rate (2017-2022)
-
Figure Global Nifedipine Consumption Forecast by Country (2022-2028)
-
Figure United States Nifedipine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nifedipine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Nifedipine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nifedipine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nifedipine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nifedipine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nifedipine Controlled Release Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Nifedipine Extended Action Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Primary Pulmonary Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Nifedipine Controlled Release Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nifedipine Extended Action Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Primary Pulmonary Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Nifedipine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Nifedipine Export by Region (Top 5 Countries) (2017-2028)
-
Table Teva (Israel) (Foundation Year, Company Profile and etc.)
-
Table Teva (Israel) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva (Israel) Nifedipine Product and Service
-
Table Shyndec (China) (Foundation Year, Company Profile and etc.)
-
Table Shyndec (China) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shyndec (China) Nifedipine Product and Service
-
Table Bayer (Germany) (Foundation Year, Company Profile and etc.)
-
Table Bayer (Germany) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer (Germany) Nifedipine Product and Service
-
Table Actavis (USA) (Foundation Year, Company Profile and etc.)
-
Table Actavis (USA) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis (USA) Nifedipine Product and Service
-
Table Pfizer (USA) (Foundation Year, Company Profile and etc.)
-
Table Pfizer (USA) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer (USA) Nifedipine Product and Service
-
Table Huanghai (China) (Foundation Year, Company Profile and etc.)
-
Table Huanghai (China) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Huanghai (China) Nifedipine Product and Service
-
Table Honglin (China) (Foundation Year, Company Profile and etc.)
-
Table Honglin (China) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Honglin (China) Nifedipine Product and Service
-
Table Yabao (China) (Foundation Year, Company Profile and etc.)
-
Table Yabao (China) Nifedipine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yabao (China) Nifedipine Product and Service
-
